Windlas Biotech Ltd.
•₹ 993.60.55%
2026-08-21
PROS
- Company has delivered good profit growth of 33.7% CAGR over last 5 years
- Company is almost debt free
- Company has consistently been profitable over the last 5 years
- Company has delivered good sales growth of 16.2% CAGR over last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.52x)
CONS
- Receivables are growing faster than sales - a possible quality concern
- Growth is decelerating - 3Y profit CAGR (16.0%) trails the 5Y trend (33.7%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | WINDLAS | 965.60 | 29.98 | 1992.63 | 0.65 | 15.99 | -1.79 | 238.50 | 17.66 | 16.06 | 10.60 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 141 | 145 | 153 | 162 | 171 | 175 | 187 | 195 | 203 | 210 | 222 | 233 | 238 | |
| 124 | 128 | 134 | 142 | 149 | 154 | 164 | 170 | 177 | 184 | 194 | 209 | 213 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 2 | 3 | 3 | 3 | 4 | 4 | 5 | 4 | 5 | 5 | 4 | 5 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 4 | 3 | 3 | 3 | 4 | 6 | 6 | 7 | 8 | 7 | 8 | 8 | 8 |
| 15 | 16 | 18 | 20 | 23 | 18 | 20 | 20 | 21 | 23 | 24 | 20 | 20 | |
| Tax % | 23.94% | 26.19% | 23.38% | 23.78% | 24.92% | 26.38% | 22.82% | 23.40% | 21.81% | 24.03% | 24.54% | 24.89% | 20.68% |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 13 | 16 | 16 | 16 | 18 | 18 | 15 | 16 |
| 5 | 6 | 7 | 7 | 8 | 6 | 7 | 7 | 8 | 8 | 8 | 7 | 8 | |
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Mar 2023
- 141
- 124
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 0
- Depreciation
- 4
- 15
- Tax %
- 23.94%
- Net Profit
- 0
- 5
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2023
- 145
- 128
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 0
- Depreciation
- 3
- 16
- Tax %
- 26.19%
- Net Profit
- 0
- 6
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 153
- 134
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 0
- Depreciation
- 3
- 18
- Tax %
- 23.38%
- Net Profit
- 0
- 7
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 162
- 142
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 0
- Depreciation
- 3
- 20
- Tax %
- 23.78%
- Net Profit
- 0
- 7
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 171
- 149
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 0
- Depreciation
- 4
- 23
- Tax %
- 24.92%
- Net Profit
- 0
- 8
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 175
- 154
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 0
- Depreciation
- 6
- 18
- Tax %
- 26.38%
- Net Profit
- 13
- 6
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 187
- 164
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 1
- Depreciation
- 6
- 20
- Tax %
- 22.82%
- Net Profit
- 16
- 7
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 195
- 170
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 1
- Depreciation
- 7
- 20
- Tax %
- 23.40%
- Net Profit
- 16
- 7
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 203
- 177
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 1
- Depreciation
- 8
- 21
- Tax %
- 21.81%
- Net Profit
- 16
- 8
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 210
- 184
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 1
- Depreciation
- 7
- 23
- Tax %
- 24.03%
- Net Profit
- 18
- 8
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 222
- 194
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 1
- Depreciation
- 8
- 24
- Tax %
- 24.54%
- Net Profit
- 18
- 8
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 233
- 209
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 1
- Depreciation
- 8
- 20
- Tax %
- 24.89%
- Net Profit
- 15
- 7
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 238
- 213
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 1
- Depreciation
- 8
- 20
- Tax %
- 20.68%
- Net Profit
- 16
- 8
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| 352 | 307 | 329 | 428 | 466 | 513 | 631 | 760 | 904 | 904 | |
| 313 | 269 | 287 | 373 | 414 | 453 | 553 | 666 | 799 | 799 | |
| Operating Profit | 44 | 43 | 44 | 58 | 59 | 70 | 92 | 112 | 123 | — |
| OPM % | 12 | 14 | 13 | 14 | 13 | 14 | 15 | 15 | 14 | — |
| Other Income | 4 | 4 | 2 | 3 | 7 | 10 | 13 | 18 | 18 | 18 |
| Interest | 6 | 5 | 3 | 1 | 1 | 1 | 1 | 4 | 5 | 5 |
| Depreciation | 17 | 11 | 9 | 13 | 12 | 12 | 13 | 28 | 31 | 31 |
| 20 | 76 | 25 | 22 | 46 | 57 | 77 | 80 | 87 | 87 | |
| Tax % | 44 | 16 | 34 | 28 | 16 | 25 | 25 | 24 | 24 | 24 |
| Net Profit | 11 | 64 | 16 | 16 | 38 | 43 | 58 | 61 | 66 | 66 |
| EPS | 7 | 38 | 9 | 9 | 19 | 20 | 28 | 29 | 31 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 20 | 20 | 20 | 20 | 20 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 7 | 35 | 9 | 9 | 17 | 20 | 28 | 29 | 31 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 7 | 35 | 9 | 9 | 17 | 20 | 28 | 29 | 31 | — |
Mar 2018
- 352
- 313
- Operating Profit
- 44
- OPM %
- 12
- Other Income
- 4
- Interest
- 6
- Depreciation
- 17
- 20
- Tax %
- 44
- Net Profit
- 11
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2019
- 307
- 269
- Operating Profit
- 43
- OPM %
- 14
- Other Income
- 4
- Interest
- 5
- Depreciation
- 11
- 76
- Tax %
- 16
- Net Profit
- 64
- EPS
- 38
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 35
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 35
Mar 2020
- 329
- 287
- Operating Profit
- 44
- OPM %
- 13
- Other Income
- 2
- Interest
- 3
- Depreciation
- 9
- 25
- Tax %
- 34
- Net Profit
- 16
- EPS
- 9
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2021
- 428
- 373
- Operating Profit
- 58
- OPM %
- 14
- Other Income
- 3
- Interest
- 1
- Depreciation
- 13
- 22
- Tax %
- 28
- Net Profit
- 16
- EPS
- 9
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2022
- 466
- 414
- Operating Profit
- 59
- OPM %
- 13
- Other Income
- 7
- Interest
- 1
- Depreciation
- 12
- 46
- Tax %
- 16
- Net Profit
- 38
- EPS
- 19
- Dividend Payout %
- 20
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
Mar 2023
- 513
- 453
- Operating Profit
- 70
- OPM %
- 14
- Other Income
- 10
- Interest
- 1
- Depreciation
- 12
- 57
- Tax %
- 25
- Net Profit
- 43
- EPS
- 20
- Dividend Payout %
- 20
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 20
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 20
Mar 2024
- 631
- 553
- Operating Profit
- 92
- OPM %
- 15
- Other Income
- 13
- Interest
- 1
- Depreciation
- 13
- 77
- Tax %
- 25
- Net Profit
- 58
- EPS
- 28
- Dividend Payout %
- 20
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 28
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 28
Mar 2025
- 760
- 666
- Operating Profit
- 112
- OPM %
- 15
- Other Income
- 18
- Interest
- 4
- Depreciation
- 28
- 80
- Tax %
- 24
- Net Profit
- 61
- EPS
- 29
- Dividend Payout %
- 20
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 29
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 29
Mar 2026
- 904
- 799
- Operating Profit
- 123
- OPM %
- 14
- Other Income
- 18
- Interest
- 5
- Depreciation
- 31
- 87
- Tax %
- 24
- Net Profit
- 66
- EPS
- 31
- Dividend Payout %
- 20
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 31
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 31
TTM
- 904
- 799
- Operating Profit
- —
- OPM %
- —
- Other Income
- 18
- Interest
- 5
- Depreciation
- 31
- 87
- Tax %
- 24
- Net Profit
- 66
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 16%
- 3 Years:
- 21%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 33%
- 3 Years:
- 16%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- 22%
- 3 Years:
- 37%
- 1 Year:
- -3%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 13%
- 3 Years:
- 13%
- Last Year:
- 13%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - |
| 6 | 6 | 6 | 6 | 11 | 10 | 10 | 10 | 11 | |
| 117 | 187 | 203 | 193 | 382 | 389 | 435 | 490 | 551 | |
| 37 | 24 | 26 | 30 | 6 | 0 | 0 | 27 | 30 | |
| Trade Payables | 85 | 58 | 83 | 40 | 63 | 88 | 132 | 178 | 238 |
| 45 | 22 | 19 | 27 | 27 | 39 | 49 | 55 | 77 | |
| Total Liabilities | 289 | 298 | 338 | 296 | 489 | 527 | 626 | 760 | 907 |
| ASSETS | - | - | - | - | - | - | - | - | - |
| 86 | 64 | 70 | 96 | 91 | 109 | 179 | 223 | 213 | |
| Capital Work in Progress | 11 | 5 | 0 | 0 | 8 | 14 | 6 | 3 | 56 |
| 23 | 122 | 116 | 23 | 65 | 107 | 173 | 223 | 268 | |
| 35 | 19 | 49 | 41 | 59 | 75 | 62 | 81 | 62 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 136 | 167 | 227 | |
| Cash & Bank | 8 | 13 | 18 | 31 | 114 | 25 | 31 | 16 | 2 |
| 127 | 74 | 84 | 104 | 153 | 197 | 38 | 46 | 78 | |
| Total Assets | 289 | 298 | 338 | 296 | 489 | 527 | 626 | 760 | 907 |
| Total Debt | 55 | 30 | 27 | 31 | 6 | 0 | 0 | 27 | 30 |
| Net Working Capital | 1 | 24 | 43 | 101 | 288 | 232 | 260 | 276 | 306 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 218.50 | 301.96 | 327.03 | 310.59 | 180.31 | 190.89 | 213.99 | 238.80 | 265.88 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Total Debt | 55 | 30 | 27 | 31 | 6 | 0 | 0 | 27 | 30 |
| Net Working Capital | 1 | 24 | 43 | 101 | 288 | 232 | 260 | 276 | 306 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 218.50 | 301.96 | 327.03 | 310.59 | 180.31 | 190.89 | 213.99 | 238.80 | 265.88 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Mar 2018
- 6
- 117
- 37
- Trade Payables
- 85
- 45
- Total Liabilities
- 289
- 86
- Capital Work in Progress
- 11
- 23
- 35
- 0
- Cash & Bank
- 8
- 127
- Total Assets
- 289
- Total Debt
- 55
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 218.50
- Face Value
- 10.00
- Total Debt
- 55
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 218.50
- Face Value
- 10.00
Mar 2019
- 6
- 187
- 24
- Trade Payables
- 58
- 22
- Total Liabilities
- 298
- 64
- Capital Work in Progress
- 5
- 122
- 19
- 0
- Cash & Bank
- 13
- 74
- Total Assets
- 298
- Total Debt
- 30
- Net Working Capital
- 24
- Contingent Liabilities
- 0
- Book Value per Share
- 301.96
- Face Value
- 10.00
- Total Debt
- 30
- Net Working Capital
- 24
- Contingent Liabilities
- 0
- Book Value per Share
- 301.96
- Face Value
- 10.00
Mar 2020
- 6
- 203
- 26
- Trade Payables
- 83
- 19
- Total Liabilities
- 338
- 70
- Capital Work in Progress
- 0
- 116
- 49
- 0
- Cash & Bank
- 18
- 84
- Total Assets
- 338
- Total Debt
- 27
- Net Working Capital
- 43
- Contingent Liabilities
- 0
- Book Value per Share
- 327.03
- Face Value
- 10.00
- Total Debt
- 27
- Net Working Capital
- 43
- Contingent Liabilities
- 0
- Book Value per Share
- 327.03
- Face Value
- 10.00
Mar 2021
- 6
- 193
- 30
- Trade Payables
- 40
- 27
- Total Liabilities
- 296
- 96
- Capital Work in Progress
- 0
- 23
- 41
- 0
- Cash & Bank
- 31
- 104
- Total Assets
- 296
- Total Debt
- 31
- Net Working Capital
- 101
- Contingent Liabilities
- 0
- Book Value per Share
- 310.59
- Face Value
- 10.00
- Total Debt
- 31
- Net Working Capital
- 101
- Contingent Liabilities
- 0
- Book Value per Share
- 310.59
- Face Value
- 10.00
Mar 2022
- 11
- 382
- 6
- Trade Payables
- 63
- 27
- Total Liabilities
- 489
- 91
- Capital Work in Progress
- 8
- 65
- 59
- 0
- Cash & Bank
- 114
- 153
- Total Assets
- 489
- Total Debt
- 6
- Net Working Capital
- 288
- Contingent Liabilities
- 0
- Book Value per Share
- 180.31
- Face Value
- 5.00
- Total Debt
- 6
- Net Working Capital
- 288
- Contingent Liabilities
- 0
- Book Value per Share
- 180.31
- Face Value
- 5.00
Mar 2023
- 10
- 389
- 0
- Trade Payables
- 88
- 39
- Total Liabilities
- 527
- 109
- Capital Work in Progress
- 14
- 107
- 75
- 0
- Cash & Bank
- 25
- 197
- Total Assets
- 527
- Total Debt
- 0
- Net Working Capital
- 232
- Contingent Liabilities
- 0
- Book Value per Share
- 190.89
- Face Value
- 5.00
- Total Debt
- 0
- Net Working Capital
- 232
- Contingent Liabilities
- 0
- Book Value per Share
- 190.89
- Face Value
- 5.00
Mar 2024
- 10
- 435
- 0
- Trade Payables
- 132
- 49
- Total Liabilities
- 626
- 179
- Capital Work in Progress
- 6
- 173
- 62
- 136
- Cash & Bank
- 31
- 38
- Total Assets
- 626
- Total Debt
- 0
- Net Working Capital
- 260
- Contingent Liabilities
- 0
- Book Value per Share
- 213.99
- Face Value
- 5.00
- Total Debt
- 0
- Net Working Capital
- 260
- Contingent Liabilities
- 0
- Book Value per Share
- 213.99
- Face Value
- 5.00
Mar 2025
- 10
- 490
- 27
- Trade Payables
- 178
- 55
- Total Liabilities
- 760
- 223
- Capital Work in Progress
- 3
- 223
- 81
- 167
- Cash & Bank
- 16
- 46
- Total Assets
- 760
- Total Debt
- 27
- Net Working Capital
- 276
- Contingent Liabilities
- 0
- Book Value per Share
- 238.80
- Face Value
- 5.00
- Total Debt
- 27
- Net Working Capital
- 276
- Contingent Liabilities
- 0
- Book Value per Share
- 238.80
- Face Value
- 5.00
Mar 2026
- 11
- 551
- 30
- Trade Payables
- 238
- 77
- Total Liabilities
- 907
- 213
- Capital Work in Progress
- 56
- 268
- 62
- 227
- Cash & Bank
- 2
- 78
- Total Assets
- 907
- Total Debt
- 30
- Net Working Capital
- 306
- Contingent Liabilities
- 0
- Book Value per Share
- 265.88
- Face Value
- 5.00
- Total Debt
- 30
- Net Working Capital
- 306
- Contingent Liabilities
- 0
- Book Value per Share
- 265.88
- Face Value
- 5.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 35 | 19 | 25 | 11 | 9 | 61 | 109 | 68 | 105 | |
| Cash from Investing | -11 | -5 | -14 | -20 | -155 | -14 | -92 | -74 | -92 |
| Cash from Financing | -26 | -6 | -5 | 1 | 130 | -44 | -15 | 1 | -13 |
| -2 | 7 | 5 | -8 | -15 | 3 | 2 | -5 | 0 | |
| Free Cash Flow | 35 | 19 | 25 | -93 | 9 | 24 | 37 | -0 | 31 |
| OCF / Net Profit | 3.11 | 0.29 | 1.54 | 0.74 | 0.24 | 1.43 | 1.87 | 1.12 | 1.58 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -16 | 2 | -24 | 101 |
| OCF / Net Profit | 3.11 | 0.29 | 1.54 | 0.74 | 0.24 | 1.43 | 1.87 | 1.12 | 1.58 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -16 | 2 | -24 | 101 |
Mar 2018
- 35
- Cash from Investing
- -11
- Cash from Financing
- -26
- -2
- Free Cash Flow
- 35
- OCF / Net Profit
- 3.11
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 3.11
- Cumulative 5-Year FCF
- 0
Mar 2019
- 19
- Cash from Investing
- -5
- Cash from Financing
- -6
- 7
- Free Cash Flow
- 19
- OCF / Net Profit
- 0.29
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.29
- Cumulative 5-Year FCF
- 0
Mar 2020
- 25
- Cash from Investing
- -14
- Cash from Financing
- -5
- 5
- Free Cash Flow
- 25
- OCF / Net Profit
- 1.54
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.54
- Cumulative 5-Year FCF
- 0
Mar 2021
- 11
- Cash from Investing
- -20
- Cash from Financing
- 1
- -8
- Free Cash Flow
- -93
- OCF / Net Profit
- 0.74
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.74
- Cumulative 5-Year FCF
- 0
Mar 2022
- 9
- Cash from Investing
- -155
- Cash from Financing
- 130
- -15
- Free Cash Flow
- 9
- OCF / Net Profit
- 0.24
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.24
- Cumulative 5-Year FCF
- 0
Mar 2023
- 61
- Cash from Investing
- -14
- Cash from Financing
- -44
- 3
- Free Cash Flow
- 24
- OCF / Net Profit
- 1.43
- Cumulative 5-Year FCF
- -16
- OCF / Net Profit
- 1.43
- Cumulative 5-Year FCF
- -16
Mar 2024
- 109
- Cash from Investing
- -92
- Cash from Financing
- -15
- 2
- Free Cash Flow
- 37
- OCF / Net Profit
- 1.87
- Cumulative 5-Year FCF
- 2
- OCF / Net Profit
- 1.87
- Cumulative 5-Year FCF
- 2
Mar 2025
- 68
- Cash from Investing
- -74
- Cash from Financing
- 1
- -5
- Free Cash Flow
- -0
- OCF / Net Profit
- 1.12
- Cumulative 5-Year FCF
- -24
- OCF / Net Profit
- 1.12
- Cumulative 5-Year FCF
- -24
Mar 2026
- 105
- Cash from Investing
- -92
- Cash from Financing
- -13
- 0
- Free Cash Flow
- 31
- OCF / Net Profit
- 1.58
- Cumulative 5-Year FCF
- 101
- OCF / Net Profit
- 1.58
- Cumulative 5-Year FCF
- 101
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 20.04 | 99.55 | 25.29 | 24.70 | 17.48 | 20.37 | 27.98 | 29.10 | 31.49 |
| Book Value (₹) | 218.50 | 301.96 | 327.03 | 310.59 | 180.31 | 190.89 | 213.99 | 238.80 | 265.88 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 3.50 | 4.00 | 5.50 | 5.80 | 6.30 |
| Cash EPS (₹) | 17.99 | 40.87 | 14.01 | 15.67 | 23.05 | 26.28 | 34.44 | 42.45 | 46.05 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 12.36% | 13.92% | 13.37% | 13.51% | 12.69% | 13.68% | 12.39% | 12.38% | 11.59% |
| Net Margin % | 3.18% | 20.77% | 4.93% | 3.64% | 8.17% | 8.31% | 9.22% | 8.03% | 7.35% |
| ROE % | 9.17% | 40.43% | 8.04% | 7.62% | 12.87% | 10.76% | 13.78% | 12.90% | 12.52% |
| ROCE % | 14.61% | 40.11% | 11.81% | 9.85% | 14.88% | 14.39% | 18.34% | 17.12% | 16.06% |
| 3.87% | 21.75% | 5.10% | 4.91% | 9.70% | 8.39% | 10.10% | 8.80% | 7.97% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - |
| Debtor Days | 69 | 76 | 70 | 61 | 74 | 81 | 73 | 73 | 80 |
| Inventory Days | 36 | 32 | 38 | 39 | 39 | 47 | 40 | 34 | 29 |
| Payable Days | 136 | 139 | 122 | 86 | 65 | 92 | 107 | 124 | 140 |
| -31 | -30 | -14 | 14 | 49 | 36 | 6 | -17 | -32 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.44x | 0.15x | 0.13x | 0.16x | 0.02x | 0.00x | 0.00x | 0.05x | 0.05x |
| Interest Coverage (x) | 4.07x | 16.73x | 10.77x | 17.85x | 33.16x | 73.38x | 70.77x | 19.20x | 19.02x |
| 1.01x | 1.25x | 1.34x | 2.08x | 4.06x | 2.92x | 2.51x | 2.11x | 1.95x | |
| GROWTH | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | -12.76% | 7.02% | 30.03% | 8.96% | 10.12% | 22.97% | 20.43% | 18.98% |
| Operating Profit Growth % | 0.00% | -1.78% | 2.78% | 31.47% | 2.33% | 18.71% | 30.56% | 22.35% | 9.29% |
| Net Profit Growth % | 0.00% | 469.94% | -74.60% | -3.97% | 144.63% | 11.91% | 36.51% | 4.82% | 8.96% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 37.35% | 4.01% | 8.20% | |
| VALUATION | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 18.31x | 35.78x | 23.43x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 2.39x | 4.36x | 2.77x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.07% | 0.56% | 0.85% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 11.29x | 19.56x | 12.93x |
Mar 2018
- EPS (₹)
- 20.04
- Book Value (₹)
- 218.50
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 17.99
- Operating Margin %
- 12.36%
- Net Margin %
- 3.18%
- ROE %
- 9.17%
- ROCE %
- 14.61%
- 3.87%
- Debtor Days
- 69
- Inventory Days
- 36
- Payable Days
- 136
- -31
- Debt to Equity (x)
- 0.44x
- Interest Coverage (x)
- 4.07x
- 1.01x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 99.55
- Book Value (₹)
- 301.96
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 40.87
- Operating Margin %
- 13.92%
- Net Margin %
- 20.77%
- ROE %
- 40.43%
- ROCE %
- 40.11%
- 21.75%
- Debtor Days
- 76
- Inventory Days
- 32
- Payable Days
- 139
- -30
- Debt to Equity (x)
- 0.15x
- Interest Coverage (x)
- 16.73x
- 1.25x
- Revenue Growth %
- -12.76%
- Operating Profit Growth %
- -1.78%
- Net Profit Growth %
- 469.94%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 25.29
- Book Value (₹)
- 327.03
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 14.01
- Operating Margin %
- 13.37%
- Net Margin %
- 4.93%
- ROE %
- 8.04%
- ROCE %
- 11.81%
- 5.10%
- Debtor Days
- 70
- Inventory Days
- 38
- Payable Days
- 122
- -14
- Debt to Equity (x)
- 0.13x
- Interest Coverage (x)
- 10.77x
- 1.34x
- Revenue Growth %
- 7.02%
- Operating Profit Growth %
- 2.78%
- Net Profit Growth %
- -74.60%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 24.70
- Book Value (₹)
- 310.59
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 15.67
- Operating Margin %
- 13.51%
- Net Margin %
- 3.64%
- ROE %
- 7.62%
- ROCE %
- 9.85%
- 4.91%
- Debtor Days
- 61
- Inventory Days
- 39
- Payable Days
- 86
- 14
- Debt to Equity (x)
- 0.16x
- Interest Coverage (x)
- 17.85x
- 2.08x
- Revenue Growth %
- 30.03%
- Operating Profit Growth %
- 31.47%
- Net Profit Growth %
- -3.97%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 17.48
- Book Value (₹)
- 180.31
- Dividend per Share (₹)
- 3.50
- Cash EPS (₹)
- 23.05
- Operating Margin %
- 12.69%
- Net Margin %
- 8.17%
- ROE %
- 12.87%
- ROCE %
- 14.88%
- 9.70%
- Debtor Days
- 74
- Inventory Days
- 39
- Payable Days
- 65
- 49
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 33.16x
- 4.06x
- Revenue Growth %
- 8.96%
- Operating Profit Growth %
- 2.33%
- Net Profit Growth %
- 144.63%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 20.37
- Book Value (₹)
- 190.89
- Dividend per Share (₹)
- 4.00
- Cash EPS (₹)
- 26.28
- Operating Margin %
- 13.68%
- Net Margin %
- 8.31%
- ROE %
- 10.76%
- ROCE %
- 14.39%
- 8.39%
- Debtor Days
- 81
- Inventory Days
- 47
- Payable Days
- 92
- 36
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 73.38x
- 2.92x
- Revenue Growth %
- 10.12%
- Operating Profit Growth %
- 18.71%
- Net Profit Growth %
- 11.91%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 27.98
- Book Value (₹)
- 213.99
- Dividend per Share (₹)
- 5.50
- Cash EPS (₹)
- 34.44
- Operating Margin %
- 12.39%
- Net Margin %
- 9.22%
- ROE %
- 13.78%
- ROCE %
- 18.34%
- 10.10%
- Debtor Days
- 73
- Inventory Days
- 40
- Payable Days
- 107
- 6
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 70.77x
- 2.51x
- Revenue Growth %
- 22.97%
- Operating Profit Growth %
- 30.56%
- Net Profit Growth %
- 36.51%
- 37.35%
- P/E (x)
- 18.31x
- P/B (x)
- 2.39x
- Dividend Yield %
- 1.07%
- 11.29x
Mar 2025
- EPS (₹)
- 29.10
- Book Value (₹)
- 238.80
- Dividend per Share (₹)
- 5.80
- Cash EPS (₹)
- 42.45
- Operating Margin %
- 12.38%
- Net Margin %
- 8.03%
- ROE %
- 12.90%
- ROCE %
- 17.12%
- 8.80%
- Debtor Days
- 73
- Inventory Days
- 34
- Payable Days
- 124
- -17
- Debt to Equity (x)
- 0.05x
- Interest Coverage (x)
- 19.20x
- 2.11x
- Revenue Growth %
- 20.43%
- Operating Profit Growth %
- 22.35%
- Net Profit Growth %
- 4.82%
- 4.01%
- P/E (x)
- 35.78x
- P/B (x)
- 4.36x
- Dividend Yield %
- 0.56%
- 19.56x
Mar 2026
- EPS (₹)
- 31.49
- Book Value (₹)
- 265.88
- Dividend per Share (₹)
- 6.30
- Cash EPS (₹)
- 46.05
- Operating Margin %
- 11.59%
- Net Margin %
- 7.35%
- ROE %
- 12.52%
- ROCE %
- 16.06%
- 7.97%
- Debtor Days
- 80
- Inventory Days
- 29
- Payable Days
- 140
- -32
- Debt to Equity (x)
- 0.05x
- Interest Coverage (x)
- 19.02x
- 1.95x
- Revenue Growth %
- 18.98%
- Operating Profit Growth %
- 9.29%
- Net Profit Growth %
- 8.96%
- 8.20%
- P/E (x)
- 23.43x
- P/B (x)
- 2.77x
- Dividend Yield %
- 0.85%
- 12.93x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-14 - Windlas Biotech Limited has informed the Exchange about earnings call transcript of Q1 FY27
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-11 - Windlas Biotech Limited has informed the Exchange about Link of Recording
Annual Reports
Credit Ratings
- Credit Rating
2026-06-29 - Windlas Biotech Limited has informed the Exchange about Credit Rating
Concalls
Aug 2026
May 2026
Feb 2026